LDP Lawmakers Discuss Re-Pricing of Opdivo; Some Say Application of Huge Seller Rule Reasonable

Senior lawmakers of the ruling Liberal Democratic Party (LDP) well versed in health policies met on November 8 to discuss the re-pricing of Ono Pharmaceutical’s immuno-oncology med Opdivo (nivolumab), among other health-related issues. According to several lawmakers who attended the...read more